Skip to main content

Afinitor Disperz Prices, Coupons, Copay Cards & Patient Assistance

Afinitor Disperz (everolimus) is a member of the mTOR inhibitors drug class and is commonly used for Subependymal Giant Cell Astrocytoma, and Tuberous Sclerosis Complex.

The cost for Afinitor Disperz 2 mg oral tablet, dispersible is around $19,442 for a supply of 28 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

A generic version of Afinitor Disperz is available. See everolimus prices (from $11,293.10 for 28 tablets).

Afinitor Disperz prices

Oral Tablet, Dispersible

2 mg

Afinitor Disperz oral tablet, dispersible

 from $19,441.84

for 28 tablets
Quantity Per unit Price
28 (4 x 7 each) $694.35 $19,441.84

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

3 mg

Afinitor Disperz oral tablet, dispersible

 from $19,636.48

for 28 tablets
Quantity Per unit Price
28 (4 x 7 each) $701.30 $19,636.48

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

5 mg

Afinitor Disperz oral tablet, dispersible

 from $20,437.22

for 28 tablets
Quantity Per unit Price
28 (4 x 7 each) $729.90 $20,437.22

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Afinitor Disperz Coupons, Copay Cards and Rebates

Afinitor Disperz offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

No manufacturer promotions could be found for this medication.

Patient Assistance & Copay Programs for Afinitor Disperz

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)

Eligibility requirements:
  1. Contact program for details.
  2. Based on FPL
  3. Not specified
  4. Must be residing in the US or US territory
  5. Fabhalta: To start the application process apply to support.Fabhalta.com or (833) 993-2242. Kesimpta: To start the application process apply to Alongside™ Kesimpta at www.Kesimpta.com or (855) 537-4678. Kisqali: To start the application process apply to support.Kisqali.com or (866) 433-8000. Leqvio: To start the application process apply to Leqvio Service Center at www.Leqvio.com or (833) 537-8462. Lutathera: To start the application process call (844) 638-7222. Pluvicto: To start the application process call (844) 638-7222. Scemblix: To start the application process apply to support.Scemblix.com or (866) 433-8000. All medication will be shipped directly to the patient, unless otherwise noted. Please contact the program for a complete product listing. www.pap.novartis.com
Applicable drugs:
  • Afinitor Disperz (everolimus) Tablet for Oral Suspension

More information please phone: 800-277-2254 Visit Website

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Afinitor Disperz (everolimus) Tablet for Oral Suspension

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Afinitor Disperz (everolimus) Tablet for Oral Suspension

More information please phone: 866-316-7263 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.